ScoreWhy is Zim Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -15.97% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.90% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 8 consecutive quarters
- PBT LESS OI(Q) At Rs -1.22 cr has Fallen at -119.06%
- PAT(9M) At Rs 7.72 cr has Grown at -31.44%
- ROCE(HY) Lowest at 5.08%
3
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zim Laboratories for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zim Laboratories
9.11%
0.14
55.05%
Sensex
-6.43%
-0.45
13.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.03%
EBIT Growth (5y)
-15.97%
EBIT to Interest (avg)
3.14
Debt to EBITDA (avg)
2.30
Net Debt to Equity (avg)
0.28
Sales to Capital Employed (avg)
1.20
Tax Ratio
28.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
8.29%
ROE (avg)
6.90%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
105
Industry P/E
34
Price to Book Value
2.07
EV to EBIT
69.27
EV to EBITDA
23.17
EV to Capital Employed
1.84
EV to Sales
1.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.65%
ROE (Latest)
1.98%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
PAT(Latest six months)
Higher at Rs 8.14 cr
-10What is not working for the Company
PBT LESS OI(Q)
At Rs -1.22 cr has Fallen at -119.06%
PAT(9M)
At Rs 7.72 cr has Grown at -31.44%
ROCE(HY)
Lowest at 5.08%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.43 times
NON-OPERATING INCOME(Q)
is 124.70 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Zim Laboratories
Profit After Tax (PAT) - Latest six months
Higher at Rs 8.14 cr
than preceding 12 month period ended Mar 2026 of Rs 6.59 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Zim Laboratories
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.22 cr has Fallen at -119.06%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 124.70 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Debtors Turnover Ratio- Half Yearly
Lowest at 3.43 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 6.16 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
